Unseld, Anna
Boehringer Ingelheim (Germany)
2 papers on CoChat
Most cited papers
- Verified
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
le Roux, C. W., Steen, O., Lucas, K. J., Startseva, E., Unseld, A., & Hennige, A. M. (2024) · The Lancet Diabetes & Endocrinology
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 237
- Verified
51-OR: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of BI 456906 in People with Overweight/Obesity
LE ROUX, C., STEEN, O., LUCAS, K. J., STARTSEVA, E., UNSELD, A., & HENNIGE, A. M. (2023) · Diabetes
Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity
Cited by 24
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free